PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-05-07

Date Title Company
07-May-2025 Black Book Research Celebrates Women's Health Month With Complimentary Release of Comprehensive 2025 Industry Report on Women's Health IT Innovations ACCESS Newswire
07-May-2025 Theriva Biologics Announces Pricing of $7.5 Million Public Offering Theriva Biologics
07-May-2025 AcutePet Urgent Care Opens in Summerville, SC - Bringing Affordable Emergency-Level Care to Local Pet Owners ACCESS Newswire
07-May-2025 Theriva™ Biologics Announces Primary Endpoints for Efficacy and Safety Achieved in VIRAGE Phase 2b Clinical Trial of VCN-01 with Gemcitabine/nab-Paclitaxel in Newly-Diagnosed Metastatic Pancreatic Cancer Patients Theriva™ Biologics
07-May-2025 Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis Tiziana Life Sciences
07-May-2025 UK-India trade agreement does not support UK life sciences ambitions, says ABPI ABPI
07-May-2025 Personalized Treatment Plans Influence European Public’s Willingness to Share Health Data Johnson & Johnson MedTech
07-May-2025 Medacta announces the results of today's Annual General Meeting Medacta Group SA
07-May-2025 Enhertu followed by THP before surgery showed statistically significant and clinically meaningful improvement in pathologic complete response in patients with high-risk HER2-positive early-stage breast cancer in DESTINY-Breast11 Phase III trial Astrazeneca
07-May-2025 Fresenius Q1/25: Strong start to 2025 – #FutureFresenius Rejuvenate phase kicked-off with excellent momentum Fresenius
07-May-2025 Emmes Groups' OptymEdge to launch the first dedicated ophthalmology clinical trial platform at ARVO 2025 OptymEdge, an Emmes Group company.
07-May-2025 Viatris Announces Quarterly Dividend Viatris
07-May-2025 Powering the Future of Lupus Treatments Worldwide Clinical Trials
07-May-2025 Global ICON survey shows need for more efficient obesity clinical trial design to realise full potential of next-gen multi-indication therapies ICON
07-May-2025 Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025 Novo Nordisk
07-May-2025 Gilead’s Livdelzi® (Seladelpar) Demonstrated Consistent Efficacy and Safety Regardless of Prior Treatment History in New Data Presented at EASL 2025 Gilead
07-May-2025 Final Data From the Phase 3 MYR301 Study Demonstrated Longer Treatment With Bulevirtide Was Associated With Sustaining Undetectability After Stopping Treatment Gilead
07-May-2025 Travel Nurses, Inc. Celebrates Nurses Week 2025 ACCESS Newswire
07-May-2025 The Increasing Value Of The Lung Cancer Therapeutics Market By 2035 Market Business Insights
07-May-2025 Bulletin from the Annual General Meeting in Ascelia Pharma AB on 7 May 2025 ACCESS Newswire